Skip to main content
. 2022 Dec;14(12):5087–5096. doi: 10.21037/jtd-22-1306

Table 2. Respiratory co-morbidities of participants who died.

Variables Subtypes Deaths: no chronic cough Deaths: dry chronic cough Deaths: productive chronic cough
N Weighted % N Weighted % N Weighted %
Wheeze No 343 1.16 40 1.39 40 2.50
Yes 75 1.57 15 0.86 45 4.13
Shortness of breath up hill No 398 1.15 53 1.25 70 3.01
Yes 21 3.87 2 1.01 15 5.66
Chest pain No 277 1.13 34 1.21 42 2.19
Yes 75 0.92 10 0.95 23 4.02
Asthma only 30 0.90 3 0.91 7 2.79
COPD only 35 4.13 4 2.38 24 7.77
Asthma and COPD 15 3.87 5 2.46 6 2.50
No asthma or COPD 335 1.14 43 1.18 47 2.75
Pneumonia No 394 1.16 51 1.23 73 3.17
Yes 24 3.63 4 1.40 12 4.75
Influenza No 388 1.20 52 1.29 73 3.11
Yes 29 2.41 3 0.49 12 4.66
FEV1/FVC <0.7 52 2.47 10 2.05 13 2.18
≥0.7 179 2.54 19 0.63 26 2.54
FEV1 % predicted <80% 65 2.60 13 1.74 19 3.81
≥80% 166 2.66 16 0.61 20 1.98

Data shown in those with no chronic cough, dry chronic cough and productive. COPD, obstructive pulmonary disease; FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity.